Back to Rankings

RGEN

RepligenD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RGEN vs peer average
28/100
RGEN vs. peer average (D vs. C)
Grade spread
A 3 · C 2 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PCVX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.85B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPCVXVaxcyte
RGEN
Repligen
PCVX
Vaxcyte
Grade
D
D
Momentum
21
15
Value
59
41
Sentiment
-
88
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs PCVX

RGEN / PCVX
Grade Position
Below peers
RGEN vs. peer average (D vs. C)
28/100
Momentum
21
RGEN
Value
59
RGEN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RGEN
1
PCVX
Vaxcyte Inc Common
D
40/100
Even
2
ALKS
Alkermes plc Common
A
100/100
-3
3
LEGN
Legend Biotech Corp ADR
C
60/100
-1
4
GRFS
Grifols SA Class B ADR
D
40/100
Even
5
PRAX
Praxis Precision Medicines Inc Common
A
100/100
-3
PCVX is the first peer returned for this comparison set.